Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138184512> ?p ?o ?g. }
- W2138184512 endingPage "1947" @default.
- W2138184512 startingPage "1937" @default.
- W2138184512 abstract "Abstract The safety of oncolytic viruses for treatment of cancer has been shown in clinical trials while antitumor efficacy has often remained modest. As expression of the coxsackie‐adenovirus receptor may be variable in advanced tumors, we developed Ad5‐D24‐RGD, a p16/Rb pathway selective oncolytic adenovirus featuring RGD‐4C modification of the fiber. This allows viral entry through alpha‐v‐beta integrins frequently highly expressed in advanced tumors. Advanced tumors are often immunosuppressive which results in lack of tumor eradication despite abnormal epitopes being present. Granulocyte‐macrophage colony stimulating factor (GMCSF) is a potent activator of immune system with established antitumor properties. To stimulate antitumor immunity and break tumor associated immunotolerance, we constructed Ad5‐RGD‐D24‐GMCSF, featuring GMCSF controlled by the adenoviral E3 promoter. Preliminary safety of Ad5‐D24‐RGD and Ad5‐RGD‐D24‐GMCSF for treatment of human cancer was established. Treatments with Ad5‐D24‐RGD (N = 9) and Ad5‐RGD‐D24‐GMCSF (N = 7) were well tolerated. Typical side effects were grade 1‐2 fatigue, fever and injection site pain. 77% (10/13) of evaluable patients showed virus in circulation for at least 2 weeks. In 3 out of 6 evaluable patients, disease previously progressing stabilized after a single treatment with Ad5‐RGD‐D24‐GMCSF. In addition, 2/3 patients had stabilization or reduction in tumor marker levels. All patients treated with Ad5‐D24‐RGD showed disease progression in radiological analysis, although 3/6 had temporary reduction or stabilization of marker levels. Induction of tumor and adenovirus specific immunity was demonstrated with ELISPOT in Ad5‐RGD‐D24‐GMCSF treated patients. RGD modified oncolytic adenoviruses with or without GMCSF seem safe for further clinical development." @default.
- W2138184512 created "2016-06-24" @default.
- W2138184512 creator A5003003951 @default.
- W2138184512 creator A5019692737 @default.
- W2138184512 creator A5021294660 @default.
- W2138184512 creator A5023641393 @default.
- W2138184512 creator A5023649972 @default.
- W2138184512 creator A5027724514 @default.
- W2138184512 creator A5030348220 @default.
- W2138184512 creator A5030358743 @default.
- W2138184512 creator A5031533220 @default.
- W2138184512 creator A5034057474 @default.
- W2138184512 creator A5042445775 @default.
- W2138184512 creator A5048438263 @default.
- W2138184512 creator A5054248211 @default.
- W2138184512 creator A5062078543 @default.
- W2138184512 creator A5062159999 @default.
- W2138184512 creator A5064546761 @default.
- W2138184512 creator A5068823708 @default.
- W2138184512 creator A5078974869 @default.
- W2138184512 creator A5080754209 @default.
- W2138184512 creator A5084843868 @default.
- W2138184512 creator A5090221441 @default.
- W2138184512 date "2011-08-08" @default.
- W2138184512 modified "2023-10-18" @default.
- W2138184512 title "Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors" @default.
- W2138184512 cites W1491631791 @default.
- W2138184512 cites W1661544713 @default.
- W2138184512 cites W1969024531 @default.
- W2138184512 cites W1978847370 @default.
- W2138184512 cites W1985842299 @default.
- W2138184512 cites W2013756986 @default.
- W2138184512 cites W2014183131 @default.
- W2138184512 cites W2022386076 @default.
- W2138184512 cites W2022831267 @default.
- W2138184512 cites W2028673858 @default.
- W2138184512 cites W2034905616 @default.
- W2138184512 cites W2041459926 @default.
- W2138184512 cites W2042351268 @default.
- W2138184512 cites W2044422127 @default.
- W2138184512 cites W2054767441 @default.
- W2138184512 cites W2061907704 @default.
- W2138184512 cites W2070248644 @default.
- W2138184512 cites W2073310925 @default.
- W2138184512 cites W2077137690 @default.
- W2138184512 cites W2079578429 @default.
- W2138184512 cites W2082150850 @default.
- W2138184512 cites W2091123006 @default.
- W2138184512 cites W2093424805 @default.
- W2138184512 cites W2096232093 @default.
- W2138184512 cites W2100031414 @default.
- W2138184512 cites W2101058247 @default.
- W2138184512 cites W2102807955 @default.
- W2138184512 cites W2103425474 @default.
- W2138184512 cites W2110592777 @default.
- W2138184512 cites W2110779133 @default.
- W2138184512 cites W2113031045 @default.
- W2138184512 cites W2120747271 @default.
- W2138184512 cites W2135875837 @default.
- W2138184512 cites W2137049683 @default.
- W2138184512 cites W2143745678 @default.
- W2138184512 cites W2147961945 @default.
- W2138184512 cites W2154175604 @default.
- W2138184512 cites W2156932621 @default.
- W2138184512 cites W2157113469 @default.
- W2138184512 cites W2159143830 @default.
- W2138184512 cites W2162907476 @default.
- W2138184512 cites W2165320653 @default.
- W2138184512 cites W2168346184 @default.
- W2138184512 cites W2204518675 @default.
- W2138184512 doi "https://doi.org/10.1002/ijc.26216" @default.
- W2138184512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21630267" @default.
- W2138184512 hasPublicationYear "2011" @default.
- W2138184512 type Work @default.
- W2138184512 sameAs 2138184512 @default.
- W2138184512 citedByCount "81" @default.
- W2138184512 countsByYear W21381845122012 @default.
- W2138184512 countsByYear W21381845122013 @default.
- W2138184512 countsByYear W21381845122014 @default.
- W2138184512 countsByYear W21381845122015 @default.
- W2138184512 countsByYear W21381845122016 @default.
- W2138184512 countsByYear W21381845122017 @default.
- W2138184512 countsByYear W21381845122018 @default.
- W2138184512 countsByYear W21381845122019 @default.
- W2138184512 countsByYear W21381845122020 @default.
- W2138184512 countsByYear W21381845122021 @default.
- W2138184512 countsByYear W21381845122022 @default.
- W2138184512 countsByYear W21381845122023 @default.
- W2138184512 crossrefType "journal-article" @default.
- W2138184512 hasAuthorship W2138184512A5003003951 @default.
- W2138184512 hasAuthorship W2138184512A5019692737 @default.
- W2138184512 hasAuthorship W2138184512A5021294660 @default.
- W2138184512 hasAuthorship W2138184512A5023641393 @default.
- W2138184512 hasAuthorship W2138184512A5023649972 @default.
- W2138184512 hasAuthorship W2138184512A5027724514 @default.
- W2138184512 hasAuthorship W2138184512A5030348220 @default.
- W2138184512 hasAuthorship W2138184512A5030358743 @default.
- W2138184512 hasAuthorship W2138184512A5031533220 @default.